Invesco Ltd. - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 130 filers reported holding TCR2 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$114,000
-43.3%
13,419
+9.8%
0.00%
Q2 2021$201,000
-96.8%
12,220
-94.0%
0.00%
-100.0%
Q4 2020$6,324,000
+597.2%
204,486
+358.4%
0.00%
Q3 2020$907,000
+42.6%
44,609
+7.8%
0.00%
Q2 2020$636,00041,3630.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders